Schizophrenia drug patent survives Section 101 test at Federal Circuit
In its important Vanda Pharmaceuticals v West-Ward Pharmaceuticals opinion, the Federal Circuit found the claims eligible at step two of the Mayo/Alice test whereas the district court found them eligible at step one
The Federal Circuit has affirmed a ruling of patent eligibility in Vanda Pharmaceuticals v West-Ward Pharmaceuticals for claims directed to a drug based upon the results of a diagnostic technique.
The patent is owned by Aventisub and exclusively licensed to...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.